Lophophine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Lophophine
Lophophine.png
Systematic (IUPAC) name
2-(7-methoxy-1,3-benzodioxol-5-yl)ethanamine
Clinical data
Pregnancy
category
  •  ?
Legal status
Routes of
administration
Oral
Identifiers
CAS Number 23693-38-1 YesY
ATC code none
PubChem CID: 90239
ChemSpider 81465 YesY
ChEMBL CHEMBL159620 YesY
Chemical data
Formula C10H13NO3
Molecular mass 195.22 g/mol
  • O1c2cc(cc(OC)c2OC1)CCN
  • InChI=1S/C10H13NO3/c1-12-8-4-7(2-3-11)5-9-10(8)14-6-13-9/h4-5H,2-3,6,11H2,1H3 YesY
  • Key:ORXQUAPZHKCCAX-UHFFFAOYSA-N YesY
  (verify)

Lophophine (MMDPEA, 3-methoxy-4,5-methylenedioxyphenethylamine) is a putative psychedelic and entactogen drug of the methylenedioxyphenethylamine class. It is the α-demethylated homologue of MMDA, and is also closely related to mescaline.

Alexander Shulgin originally suggested that lophophine may be a natural constituent of peyote (Lophophora williamsii) due to it being the only logical chemical intermediate for the biosynthesis of several tetrahydroisoquinolines known to be present in this cactus species.[1] Subsequently, lophophine was indeed shown to be a minor component of both peyote and San Pedro cactus.[2]

Shulgin reports that lophophine is active in the dosage range of 150–250 mg. He states that at these doses, lophophine has some similarity to mescaline in action, in producing a peaceful elevation of mood, euphoria, and mild enhancement of visual perception, but without the generation of closed-eye mental imagery. Shulgin also notes that (in contrast to mescaline), lophophine causes no nausea.[1]

At dosages above 300 mg, visual distortions that resemble those of standard doses of mescaline are said to begin to appear .[citation needed]

See also

References

  1. 1.0 1.1 A. Shulgin and A. Shulgin (1991). Pihkal, pp.701-702, Transform Press, Berkeley.
  2. Lua error in package.lua at line 80: module 'strict' not found.

External links